All Posts:dementia
-
Cognitive Declines Preceding Alzheimer’s Diagnosis Lead to Credit Card, Mortgage Delinquency
In the years prior to an Alzheimer’s disease or other memory disorder diagnosis, credit scores begin to weaken and payment delinquency begins to increase, concludes new research led by Georgetown University. The findings show consistent deterioration in these financial outcomes over the quarters leading up to diagnosis and that credit card and mortgage delinquencies, specifically, both increase substantially prior to diagnosis.
Category: News Release
-
Georgetown Study Explores THC/CBD Combination to Reduce Dementia-related Agitation at the End of Life
In a first-of-its-kind clinical trial, the Georgetown University Medical Center Memory Disorders Program will study the effects of an oral drug called T2:C100, which is comprised of two components found in marijuana — THC and CBD. The goal of the study is to investigate its potential to decrease agitation experienced by those with dementia at the end of life.
Category: News Release
-
Immune-Compromised People with HIV, APOE4 Gene May Have a Compounded Risk for Alzheimer’s
WASHINGTON (February 22, 2021) — People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer’s disease-related gene variant APOE4 might see a compounded adverse effect on the circuitry that impacts memory. This could eventually lead to an increased risk for dementia after […]
Category: News Release
-
Early-life Education Improves Memory in Old Age — Especially for Women
WASHINGTON (June 5, 2020) — Education appears to protect older adults, especially women, against memory loss, according to a study by investigators at Georgetown University Medical Center, published in the journal Aging, Neuropsychology, and Cognition. The results suggest that children — especially girls — who attend school for longer will have better memory abilities in […]
Category: News Release
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release
-
Seeding the Work of GUMC's Young Neuroscience Investigators
(May 30, 2013) — Talk of continued successes punctuated the conversations of more than 150 guests at Georgetown University Medical Center’s (GUMC) third annual “Music for the Mind,” a spring fundrais
Category: GUMC Stories
-
Removing Protein “Garbage” in Nerve Cells May Help Control Two Neurodegenerative Diseases
Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases — amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) — and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.
Category: News Release